Page last updated: 2024-08-26

n-hydroxysuccinimide suberic acid ester and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

n-hydroxysuccinimide suberic acid ester has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naito, M; Tsuruo, T1

Other Studies

1 other study(ies) available for n-hydroxysuccinimide suberic acid ester and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Functionally active homodimer of P-glycoprotein in multidrug-resistant tumor cells.
    Biochemical and biophysical research communications, 1992, May-29, Volume: 185, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Dihydropyridines; Doxorubicin; Drug Resistance; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macromolecular Substances; Membrane Glycoproteins; Mitolactol; Mitomycins; Precipitin Tests; Succinimides; Tumor Cells, Cultured; Verapamil; Vincristine

1992